This is a new step forward for former cancer or hepatitis C patients. The right to be forgotten will be reduced from June 1, following the publication of the Lemoine Act of February 28, 2022, ” for fairer, simpler and more transparent access to the borrower insurance market. ” Thus, they will no longer have to declare their pathology in the health questionnaire for a real estate loan application if they have completed their therapeutic protocol for at least five years.
Before that date, deadlines were different. The right to be forgotten applied 10 years after the end of treatment for cancers diagnosed after the age of 21. The five-year period only applied to people whose cancer had been detected before the age of 21.
Unsecured borrower insurance
Specifically, in the questionnaire to be completed to obtain borrower insurance, to the question “Have you undergone chemotherapy treatment in the last five years?”, Former patients will be able to answer “no”. In this way, they will be able to benefit from borrower insurance under the same conditions as the others, without surcharges. This will actually reduce the overall cost of borrowing.
“It simply came to our notice then. But this could lead to significant insurance premiums, ”remarks Maël Bernier, a spokesman for real estate loan broker Meilleurtaux.com. In fact, depending on the type of cancer, an insurance increase of up to 200% can be applied by insurance advisers.
“If you’re in remission and it’s almost five years old, it’s worth waiting until June 1st to sign up for your loan offer.” Maël Bernier.
Renegotiate on September 1 for borrowers who already have a loan
“Former patients who have already taken out their home loan and who are now in the scope of the new Lemoine law will be able to renegotiate their borrower insurance from September 1,” said Maël Bernier. The date on which it will be possible to terminate the borrower’s insurance during the loan, at any time.
This new law extends the provisions of the previous law. Indeed, several measures have been passed since 2001 to allow former cancer patients to borrow, first under the Belorgey Act and then with the Aeras Convention (“insuring and borrowing with an aggravated health risk”). ) which replaced it in 2007.